Microfluidic Devices Market Research Report - Forecast till 2027

Microfluidic Devices Market Share And Trends Analysis By Industry (In-Vitro Diagnostics, Pharmaceutical (Chips For Lab Analytics, Accurate Dispensing Devices And Micro-Reactors For Drug Synthesis), Medical Devices (Micro Pumps And Dispensing System, Inhalers, Micro-Needles And Others) And Others))), Material (Polymer, Glass, Silicon And Others), Application (Pharmaceutical And Life Science Research, Clinical And Veterinary Diagnostics, Point Of Care Diagnostics, Analytical Devices, Drug Delivery, Environmental And Industrial And Others)...

ID: MRFR/MED/0448-CR | February 2021 | Region: Global | 117 pages         

Microfluidic Devices Market

Microfluidic Devices Market is expected grow USD 17.98 Billion at a CAGR 20.56% during the forecast period.

Segmentation

By Industry In-Vitro Diagnostics Pharmaceutical
By Material Used polymer glass silicon
By Application Pharmaceutical And Life Science Research Clinical And Veterinary Diagnostics Point Of Care Diagnostics Analytical Devices Drug Delivery Environmental And Industrial

Key Players

  • Abbott Laboratories
  • HOFFMANN-LA ROCHE AG
  • Agilent Technologies Inc.
  • Siemens
  • Fluidigm
  • BIO-RAD LABORATORIES INC.
  • CEPHEID
  • RainDance Technologies Inc.
  • Dolomite Microfluidics
  • Micronit Microtechnologies
  • Johnson & Johnson Services Inc.

Drivers

  • Rising demand in genomics and proteomics
  • Increasing demand for point-of-care (POCT) testing.
Speak to Analyst Request a Free Sample

Microfluidic Devices Market Overview


The term microfluidics can be defined as obtaining, preserving, screening, monitoring, and controlling fluids at a micro-level. The fluids obtained are very minute or scaled-down in quantity. The microfluidics device model is generally used to transfer, preserve, blend and separate the fluids for further testing in laboratories. This is done while the development of new cells or in the origination of medicinal drugs and injections. Microfluidics device cell capture is also needed to detect diseases and ailments such as cancer and tumors. Microfluidics testing can also be applied to gasses and other forms of chemicals. This technology has proven to be useful in many industries. The microfluidics device industry is flourishing because of its improved effectiveness and efficient handling of miniature particles.


The Microfluidic Devices market value is foreseen to shoot up to USD 14,296.04 Million by the end of the year 2024. It will grow at a CAGR of 19.70% throughout the forecast period. Let’s hope to see much growth in this market.


COVID 19 Analysis


People across the globe are suffering from the covid19. This has weighed down the pathological labs for continuous testing and diagnosis of diseases so that they can be treated well in time. The government of every nation is investing a huge lump of their resources in research & development projects. This has made the labs and research centers more equipped than they were before.


As testing increased, a need arises for procuring and manufacturing more mobile microfluidics devices. This has made possible the rise in the sales of the point of care devices market which made possible the rapid testing of antigens.


Microfluidic Devices Market Dynamics


Drivers


The demand for genomics or complete strand of cells, and proteomes is increasing. This is the major driving force for the microfluidic devices market. The testing of microscopic cells has also become possible only with the help of microfluidic devices. As the quantity used and preserved for testing is very minute, it has made the handling less cumbersome and the results attained are quicker than primitive methods of testing


Opportunities


The major benefit of using microfluidic devices is that they use a very small quantity of chemicals which is under observation. It, altogether, lowers the cost of research. The microfluidic devices can also be connected wirelessly to cell phones. This is another boon of the advancement of scientific technology. Point of care testing is possible because of this feature.


Restraints


Businesses have to abide by the law of the land and cannot operate outside it. The rigid policies of medical authorities to provide standardized microfluidic devices may hinder the growth of the market globally. The raw material for manufacturing or assembling the testing equipment is expensive. This is another obstacle for the manufacturers of microfluidic devices.


Value Chain Analysis


Owing to unhealthy lifestyles resulting in deteriorating health, and moving up statistics of chronic diseases, it has become important to get a quicker diagnosis of diseases and finding the least hazardous cure for the same. The key players of the microfluidic devices market are launching devices, such as microfluidics device collagen gel, microfluidics device syringe pump, piezoelectric device microfluidics, microfluidics chromatography device, and others, that have made testing easier and more proficient.


Microfluidic Devices Market Segmentation


The microfluidic devices market can be divided into various segments. These are: based on industry, based on materials used, and based on application


Based on industry


This segment is further divided into in-vitro, or in a test tube, diagnosis, pharmaceutical products, and medical devices. In-vitro diagnosis alone had a market share of 50.6% in the year 2018. Pharmaceuticals are further sub-divided into chips that are used for lab analysis, accurate dispensing apparatus, and micro-reactors for drug synthesis. The medical devices include micro-pumps and dispensing systems, inhalers, micro-needles, etc.


Based on material used


Various kinds of materials used in the manufacturing of microfluidic devices are polymer, glass, silicon, and others. Polymer, as a material, is cost-effective and is easy to procure than glass or silicon. This is the reason why polymer holds the largest market share in microfluidic devices.


Based on application


The various places where microfluidic devices are installed or used are Pharmaceutical and Life Science Research institutions, Clinical and Veterinary Diagnostics labs, Point of Care Diagnosis and rapid testing centers, Drug manufacturing and delivery, Environmental and Industrial equipment, and others.


Microfluidic Devices Market Regional Analysis


Microfluidic devices market size is increasing with every passing day. It is leaving its impression in every corner of the world. The regions where they are operating include America, Europe, Asia-pacific, and the rest of the world.


America, which includes the area of North America (the US and Canada) and Latin America, eclipses above the share of all other regions. America is the largest consumer because of the increasing geriatric population, widespread infectious and chronic diseases. Larger investments in medical infrastructure by the authorities, and awareness among the general public, related to the unhealthy habits and their effects in long run, are the key driving factors.


The European region which includes Germany, UK, France, Russia, and Italy, has bagged the position of second-largest market share in the microfluidic devices market. This is because of the easy and cost-effective availability of raw material. Some of the major key players are also investing in these areas because of the ease of doing business.


Asia-Pacific region, which includes China, Japan, India, Australia, and South Korea, provides a huge market for microfluidic devices. It owns to the fact that the government of these countries is investing a large share of their resources in developing a robust medical infrastructure. This region will hit the largest CAGR throughout the period under analysis.


The rest of the world, which includes the region of the Middle East and Africa, is showing a constant but slow growth because of the limited resources with the government and lack of awareness among the general public. Low economic income is also another reason for inactive growth.


Microfluidic Devices Market Competitive Landscape


The list of major global key players involved in data analysis of the microfluidic devices market is as follows:



  • Abbott Laboratories

  • HOFFMANN-LA ROCHE AG

  • Agilent Technologies, Inc.

  • Siemens

  • Fluidigm

  • BIO-RAD LABORATORIES, INC.

  • CEPHEID

  • RainDance Technologies, Inc.

  • Dolomite Microfluidics

  • Micronit Microtechnologies

  • Johnson & Johnson Services, Inc.

  • BD

  • Elveflow

  • Perkinelmer Inc.

  • Thermo Fisher Scientific Inc.

  • BioMérieux


The above-listed companies come together in joint ventures, mergers and, acquisitions to launch new devices and products. Their main objective is to deliver cost-effective goods, hassle-free operations, and give concrete results. With advanced technologies, the key players are focusing on developing portable and mobile microfluidic devices.


Recent Developments


Various recent developments that are found in microfluidic devices market research are as follows:



  • In March of the year 2015, BD acquired all the operations of CareFusion Corporation. The cost of such a large business expansion amounted to USD12.2 billion. Coming together of these large companies has proved beneficial as they work for the betterment of patients by providing safer solutions.

  • In November of the year 2020, Dolomite Microfluidics collaborated with Millipore Sigma. Together they produced a microfluidic testing kit which was named NanoFabTx. This kit proved to be beneficial for the creation of PLGA nanoscopic substance which helped in developing new drugs.

  • In March of the year 2020, during the coronavirus, global pandemic, FDA licensed the usage of GeneXpert, which was a device produced by Cepheid, as a rapid testing kit for detection of coronavirus in a patient’s body. The kit has easy-to-use throwaway swabs and carrying material.

  • In June of the year 2020, Illumina collaborated with WellSIM Biomedical Technologies, Inc. Together they produced microfluidic devices with chip censors. They are intended to work in San Francisco and London.


Report Overview


This market research report of the Microfluidic devices market includes the following elements:



  • Market Overview

  • COVID19 Analysis

  • Market Dynamics

  • Value Chain Analysis

  • Market Segmentation

  • Regional Analysis

  • Competitive Landscape

  • Recent Developments


This Microfluidic devices market research report includes the basic meaning of microfluidics and their functioning. The microfluidics device model is generally used to transfer, preserve, blend and separate the fluids for further testing in laboratories. Due to the coronavirus, global pandemic, testing has increased. Therefore, a need arises for procuring and manufacturing more mobile microfluidics devices. The major benefit of using microfluidic devices is that they use a very small quantity of chemicals which is under observation. It, altogether, lowers the cost of research.



Report Scope:
Report Attribute/Metric Details
  Market Size   USD 14,296.04 Million
  CAGR   19.70%
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Industry, Material and Application
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Abbott Laboratories, F. HOFFMANN-LA ROCHE AG, Agilent Technologies, Inc., Siemens, Fluidigm, BIO-RAD LABORATORIES, INC., CEPHEID, RainDance Technologies, Inc., Dolomite Microfluidics, Micronit Microtechnologies, Johnson & Johnson Services, Inc., BD, Elveflow, Perkinelmer Inc., Thermo Fisher Scientific Inc., and BioMérieux
  Key Market Opportunities   The development and adoption of clinical tests are expected to drive demand for microfluidic devices.
  Key Market Drivers

  • Increase in demand for point of care testing products, microfluidic technologies for miniaturization of the chip, and rising demand in genomics and proteomics.
  • Increasing demand for point-of-care (POCT) testing.


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    The microfluidic devices market is predicted to touch USD 14, 296.04 million by 2025.

    The microfluidic devices market is predicted to grow at a 19.70% CAGR between 2020-2027.

    The Americas is predicted to have lions share in the microfluidic devices market during the forecast period.

    Increasing use in proteomics and genomics and growing demand for point of care testing products is boosting market growth.

    Strict government policies may hamper the microfluidic devices market growth.